Published in Antibiot Khimioter on January 01, 1997
Isolation of a Lactobacillus salivarius strain and purification of its bacteriocin, which is inhibitory to Campylobacter jejuni in the chicken gastrointestinal system. Antimicrob Agents Chemother (2006) 1.53
Isolation and purification of enterocin E-760 with broad antimicrobial activity against gram-positive and gram-negative bacteria. Antimicrob Agents Chemother (2007) 1.14
[The efficacy of antibacterial preparations against Pseudomonas mallei in in-vitro and in-vivo experiments]. Antibiot Khimioter (1994) 0.94
[Burkholderia mallei and Burkholderia pseudomallei. Study of immuno- and pathogenesis of glanders and melioidosis. Heterologous vaccines]. Antibiot Khimioter (1999) 0.90
Bacteriocins reduce Campylobacter colonization and alter gut morphology in turkey poults. Poult Sci (2006) 0.90
Functional characterization and biological significance of Yersinia pestis lipopolysaccharide biosynthesis genes. Biochemistry (Mosc) (2011) 0.85
[Genetic determinants of antibacterial resistance among nosocomial Escherichia coli, Klebsiella spp., and Enterobacter spp. isolates collected in Russia within 2003-2007]. Antibiot Khimioter (2010) 0.85
[Resistance of Pseudomonas mallei to tetracyclines: assessment of the feasibility of chemotherapy]. Antibiot Khimioter (1996) 0.84
Biological properties and structure of the lipopolysaccharide of a vaccine strain of Francisella tularensis generated by inactivation of a quorum sensing system gene qseC. Biochemistry (Mosc) (2010) 0.84
[The principles of the therapy of glanders in monkeys]. Zh Mikrobiol Epidemiol Immunobiol (1998) 0.83
Structural diversity and endotoxic activity of the lipopolysaccharide of Yersinia pestis. Biochemistry (Mosc) (2008) 0.83
[Genetic environments of bla(CTX-M) genes located on conjugative plasmids of Enterobacteriaceae nosocomial isolates collected in Russia within 2003-2007]. Antibiot Khimioter (2010) 0.82
[Various indices of the infectious process in treatment of glanders in monkeys]. Antibiot Khimioter (1996) 0.82
The ability of flagellum-specific Proteus vulgaris bacteriophage PV22 to interact with Campylobacter jejuni flagella in culture. Virol J (2006) 0.82
Distribution and characterization of Campylobacter spp. from Russian poultry. J Food Prot (2004) 0.82
[In vitro development of fluoroquinolone resistance in the glanders pathogen]. Antibiot Khimioter (1994) 0.81
[ELISA and PCR test systems used to detect Crimean-Congo hemorrhagic fever virus]. Vopr Virusol (2007) 0.80
[An algorithm for identification of CTX-M-type beta-lactamase genes using restriction fragment length polymorphism analysis of PCR-product]. Mol Gen Mikrobiol Virusol (2011) 0.78
[Immunogenic potential of glanders and melioidosis agents]. Vestn Ross Akad Med Nauk (1997) 0.76
[Evaluation of the potential of chemotherapy of glanders caused by Pseudomonas mallei strains resistant to sulfanilamides and trimethoprim]. Antibiot Khimioter (1994) 0.76
[Immunomodulatory properties of 2-C-methyl-D-erythritol-2,4-cyclopyrophosphate and search for its new derivatives]. Prikl Biokhim Mikrobiol (2001) 0.76
[Identification of the bacterium Pseudomonas mallei using Pseudomonas pseudomallei bacteriophages]. Mikrobiologiia (1995) 0.76
[Erysipelothrix rhusiopathiae: plasmids, resistance to antibacterial drugs]. Antibiot Khimioter (1996) 0.75
[Preparations for serodiagnosis of diseases due to causative agents of ixode tick-borne borreliosis (Lyme disease). Communication 1. Comparative study of the 1st generation enzyme immunoassay test-systems for detection of antibodies to Borrelia burkdorferi sensu lato]. Antibiot Khimioter (2004) 0.75
Monoclonal antibodies directed against lipopolysaccharide of Legionella pneumophila serogroup 1. Biochem Mol Biol Int (1998) 0.75
[CONSTRUCTION AND PROPERTIES OF THE FRANCISELLA TULARENSIS VACCINE STRAIN WITHOUT ONE COPY OF THE IGLC GENE AND WITHOUT RECA GENE]. Mol Gen Mikrobiol Virusol (2015) 0.75
[Effect of fosfidomycin on development of various infections in mice]. Antibiot Khimioter (2003) 0.75
[Design of an immunochip for separate detection of hepatitis C virus antibodies]. Klin Lab Diagn (2008) 0.75
[Pseudomonas mallei and Pseudomonas pseudomallei: introduction and maintenance of natural and recombinant plasmid replicons]. Mol Gen Mikrobiol Virusol (1995) 0.75
[The sensitivity of Pseudomonas mallei strains to antibacterial preparations in in-vitro experiments on a cell culture model]. Antibiot Khimioter (1996) 0.75
[Molecular-genetic characterization of shiga-toxin producing Escherichia coli isolated during a food-borne outbreak in St. Petersburg in 2013]. Vestn Ross Akad Med Nauk (2015) 0.75
[Transformation of pathogenic pseudomonas by plasmid DNA]. Mol Gen Mikrobiol Virusol (1992) 0.75
[Characterization of Escherichia coli strains O157:H7, isolated on the territories of the Central Federal District]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.75
[Assessing the conformity of medical devices for in vitro diagnosis: international and domestic experience]. Klin Lab Diagn (2009) 0.75
[The participation of matrix metalloproteinases-9 and TIMP-1 in formation of atrial fibrillation paroxisms in patients with metabolic syndrome]. Patol Fiziol Eksp Ter (2014) 0.75
[Sensitivity of Escherichia coli O157:H7, a pathogen of hemorrhagic colitis, to antibacterial drugs]. Antibiot Khimioter (1998) 0.75
[Molecular medicine and treatment of tuberculosis]. Probl Tuberk (2001) 0.75
[Etiology of fatal pneumonia caused by influenza A(H1N1)pdm2009 virus during the pandemic in Russia]. Vopr Virusol (2013) 0.75
[Efficacy of enterocin S760 in treatment of mice with anthrax infection due to Bacillus anthracis M-71]. Antibiot Khimioter (2011) 0.75
[The new possibilities in serologic diagnostic of Ixodes mite-borne borreliosis using ImmunoChip]. Klin Lab Diagn (2013) 0.75
[Preventive strategy for atrial fibrillation in arterial hypertension]. Klin Med (Mosk) (2009) 0.75
[Hygienic aspects of use of natural zeolites in national economy (review)]. Gig Sanit (1995) 0.75
[Preparations for serodiagnosis of diseases due to causative agents of ixodes tick-borne borreliosis (Lyme disease). Communication 3. Comparative study of enzyme immunoassay test-systems for detection of IgM to Borrelia burgdorferi sensu lato]. Antibiot Khimioter (2004) 0.75
[Hly mutants of intestinal bacteria determinants, obtained by treating recombinant plasmids with hydroxylamine]. Dokl Akad Nauk SSSR (1989) 0.75
[Interaction of thymosin fraction 3 with opiate receptors]. Biull Eksp Biol Med (1986) 0.75
[Use of enterocin S760 for prevention and treatment of experimental Salmonella infection in mice]. Zh Mikrobiol Epidemiol Immunobiol (2010) 0.75
[Comparative study of the morphology and sensitivity to damaging factors of capsular and acapsular variants of Escherichia coli CA 189]. Zh Mikrobiol Epidemiol Immunobiol (1987) 0.75
[Evaluation of the first domestic immunoenzyme recombinant test-system "Khlami-IGA-DS-Tr" for detection of class A antibodies to Chlamydia trachomatis]. Klin Lab Diagn (2002) 0.75
[Anthrax: early steps of the intracellular stage of infection development]. Mol Gen Mikrobiol Virusol (2005) 0.75
[Immunomodulating effect of an Ixodes persulcatus (Ixodidae) tick salivary gland extract on BALB/c mice lymphocytes in an in vitro system]. Med Parazitol (Mosk) (2013) 0.75
[Conjugative transfer and expression of R plasmids of the genus Pseudomonas in the cells of Pseudomonas mallei C-5]. Antibiot Khimioter (1996) 0.75
[Cell death and specifics of its regulation in tumour cells]. Ross Fiziol Zh Im I M Sechenova (2009) 0.75
[Creation of genomic DNA libraries for Pseudomonas mallei and Pseudomonas pseudomallei]. Mol Gen Mikrobiol Virusol (1997) 0.75
[Transduction of Pseudomonas mallei bacteria]. Mol Gen Mikrobiol Virusol (1993) 0.75
[Pasteurella multocida: infections in man]. Antibiot Khimioter (1997) 0.75
[The clinical significance of matrix metalloproteases in heart and vascular pathology]. Patol Fiziol Eksp Ter (2013) 0.75
[Role of bacterial toxins in pathogenesis of hemolytic-uremic syndrome, caused by enterohemorrhagic Escherichia]. Zh Mikrobiol Epidemiol Immunobiol (2001) 0.75
[Preparations for serodiagnosis of diseases due to causative agents of ixode tick-borne Borreliosis (Lyme disease). Communication 2. Comparative study of recombinant enzyme immunoassay test-systems (rELISA) for serological diagnosis of ixode tick-borne Borreliosis]. Antibiot Khimioter (2004) 0.75
[Classification of medical equipment for the diagnosis in vitro based on its potential risk. International experience and its use in the Russian Federation]. Klin Lab Diagn (2008) 0.75